The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 212 (9) , 811-816
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Role of SATB2 as a Diagnostic Marker for Tumors of Colorectal OriginAmerican Journal of Clinical Pathology, 2014
- SATB2 is a Novel Marker of Osteoblastic Differentiation and Colorectal AdenocarcinomaAdvances in Anatomic Pathology, 2014
- Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcomaVirchows Archiv, 2013
- Dentine matrix protein 1 (DMP-1) is a marker of bone-forming tumoursVirchows Archiv, 2013
- Decreased Expression of SATB2: A Novel Independent Prognostic Marker of Worse Outcome in Laryngeal Carcinoma PatientsPLOS ONE, 2012
- SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal CarcinomasAmerican Journal of Surgical Pathology, 2011
- Histopathological characterization of small cell osteosarcoma with immunohistochemistry and molecular genetic support. A study of 10 casesHistopathology, 2010
- Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumorsVirchows Archiv, 2010
- The mRNA expression of SATB1 and SATB2 in human breast cancerCancer Cell International, 2009
- Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcomaVirchows Archiv, 2008